Molecular and functional interactions of cat APOBEC3 and feline foamy and immunodeficiency virus proteins: Different ways to counteract host-encoded restriction

Virology

Volumn 424, Issue 2, 2012, Pages 138-146

  Chareza, Sarah ^a,d   Slavkovic Lukic, Dragana ^a   Liu, Yang ^a   Räthe, Ann Mareen ^a   Münk, Carsten ^b   Zabogli, Elisa ^c   Pistello, Mauro ^c   Löchelt, Martin ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b Department of Orthopedic Surgery   (Germany)

^c UNIVERSITY OF PISA   (Italy)

^d ICON Clinical Research   (Germany)

Author keywords

Anti viral restriction; APOBEC3 cytidine deaminase; Bet protein; Feline immunodeficiency virus; Foamy virus; Vif protein

Indexed keywords

APOLIPOPROTEIN B MESSENGER RNA EDITING ENZYME CATALYTIC POLYPEPTIDE 3; CYTIDINE DEAMINASE; GLUTATHIONE TRANSFERASE; MEMBRANE PROTEIN; UNCLASSIFIED DRUG;

ANTIBODY TITER; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; DIMERIZATION; FELINE FOAMY VIRUS; FELINE IMMUNODEFICIENCY VIRUS; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; MOLECULAR DYNAMICS; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY; VIRUS CELL INTERACTION; VIRUS REPLICATION;

ANIMALS; CAT DISEASES; CATS; CELL LINE; CYTIDINE DEAMINASE; FELINE ACQUIRED IMMUNODEFICIENCY SYNDROME; HOST-PATHOGEN INTERACTIONS; IMMUNODEFICIENCY VIRUS, FELINE; PROTEIN BINDING; RETROVIRIDAE INFECTIONS; SPUMAVIRUS; VIRAL PROTEINS;

FELIDAE; FELINE FOAMY VIRUS; FELINE IMMUNODEFICIENCY VIRUS; HUMAN SPUMARETROVIRUS;

EID: 84862817335     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2011.12.017     Document Type: Article

References (54)

1. Albin J.S., Harris R.S. Interactions of host APOBEC3 restriction factors with HIV-1 in vivo: implications for therapeutics. Expert Rev. Mol. Med. 2010, 12:e4.
2. Alke A., Schwantes A., Zemba M., Flügel R.M., Löchelt M. Characterization of the humoral immune response and virus replication in cats experimentally infected with feline foamy virus. Virology 2000, 275(1):170-176.
3. Alke A., Schwantes A., Kido K., Flötenmeyer M., Flügel R.M., Löchelt M. The bet gene of feline foamy virus is required for virus replication. Virology 2001, 287(2):310-320.
4. Bastone P., Truyen U., Löchelt M. Potential of zoonotic transmission of non-primate foamy viruses to humans. J. Vet. Med. B Infect. Dis. Vet. Public Health 2003, 50(9):417-423.
5. Bastone P., Romen F., Liu W., Wirtz R., Koch U., Josephson N., Langbein S., Löchelt M. Construction and characterization of efficient, stable and safe replication-deficient foamy virus vectors. Gene Ther. 2007, 14(7):613-620.
6. Baumann J.G. Intracellular restriction factors in mammalian cells-an ancient defense system finds a modern foe. Curr. HIV Res. 2006, 4(2):141-168.
7. Bennett R.P., Salter J.D., Liu X., Wedekind J.E., Smith H.C. APOBEC3G subunits self-associate via the C-terminal deaminase domain. J. Biol. Chem. 2008, 283(48):33329-33336.
8. Bieniasz P.D. Intrinsic immunity: a front-line defense against viral attack. Nat. Immunol. 2004, 5(11):1109-1115.
9. Chiu Y.L., Greene W.C. The APOBEC3 cytidine deaminases: an innate defensive network opposing exogenous retroviruses and endogenous retroelements. Annu. Rev. Immunol. 2008, 26:317-353.
10. Cullen B.R. Role and mechanism of action of the APOBEC3 family of antiretroviral resistance factors. J. Virol. 2006, 80(3):1067-1076.
11. Harris R.S., Liddament M.T. Retroviral restriction by APOBEC proteins. Nat. Rev. Immunol. 2004, 4(11):868-877.
12. Heneine W., Schweizer M., Sandstrom P., Folks T. Human infection with foamy viruses. Curr. Top. Microbiol. Immunol. 2003, 277:181-196.
13. Herchenröder O., Turek R., Neumann-Haefelin D., Rethwilm A., Schneider J. Infectious proviral clones of chimpanzee foamy virus (SFVcpz) generated by long PCR reveal close functional relatedness to human foamy virus. Virology 1995, 214(2):685-689.
14. Huthoff H., Autore F., Gallois-Montbrun S., Fraternali F., Malim M.H. RNA-dependent oligomerization of APOBEC3G is required for restriction of HIV-1. PLoS Pathog. 2009, 5(3):e1000330.
15. Katzourakis A., Gifford R.J., Tristem M., Gilbert M.T., Pybus O.G. Macroevolution of complex retroviruses. Science 2009, 325(5947):1512.
16. Khan A.S. Simian foamy virus infection in humans: prevalence and management. Expert Rev. Anti Infect. Ther. 2009, 7(5):569-580.
17. Koning F.A., Newman E.N., Kim E.Y., Kunstman K.J., Wolinsky S.M., Malim M.H. Defining APOBEC3 expression patterns in human tissues and hematopoietic cell subsets. J. Virol. 2009, 83(18):9474-9485.
18. LaRue R.S., Andresdottir V., Blanchard Y., Conticello S.G., Derse D., Emerman M., Greene W.C., Jonsson S.R., Landau N.R., Löchelt M., Malik H.S., Malim M.H., Münk C., O'Brien S.J., Pathak V.K., Strebel K., Wain-Hobson S., Yu X.F., Yuhki N., Harris R.S. Guidelines for naming nonprimate APOBEC3 genes and proteins. J. Virol. 2009, 83(2):494-497.
19. Leendertz F.H., Zirkel F., Couacy-Hymann E., Ellerbrok H., Morozov V.A., Pauli G., Hedemann C., Formenty P., Jensen S.A., Boesch C., Junglen S. Interspecies transmission of simian foamy virus in a natural predator-prey system. J. Virol. 2008, 82(15):7741-7744.
20. Leendertz S.A., Junglen S., Hedemann C., Goffe A., Calvignac S., Boesch C., Leendertz F.H. High prevalence, coinfection rate, and genetic diversity of retroviruses in wild red colobus monkeys (Piliocolobus badius badius) in Tai National Park, Cote d'Ivoire. J. Virol. 2010, 84(15):7427-7436.
21. Linial M.L. Foamy viruses are unconventional retroviruses. J. Virol. 1999, 73(3):1747-1755.
22. Linial M. Why aren't foamy viruses pathogenic?. Trends Microbiol. 2000, 8(6):284-289.
23. Liu Y., Kim Y.-B., Löchelt M. N-terminally myristoylated Feline Foamy Virus Gag allows Env-independent budding of sub-viral particles. Viruses 2011, 3:2223-2237.
24. Löchelt M. Foamy virus transactivation and gene expression. Curr. Top. Microbiol. Immunol. 2003, 277:27-61.
25. Löchelt M., Romen F., Bastone P., Muckenfuss H., Kirchner N., Kim Y.B., Truyen U., Rösler U., Battenberg M., Saib A., Flory E., Cichutek K., Münk C. The antiretroviral activity of APOBEC3 is inhibited by the foamy virus accessory Bet protein. Proc. Natl. Acad. Sci. U. S. A. 2005, 102(22):7982-7987.
26. Münk C., Zielonka J., Constabel H., Kloke B.P., Rengstl B., Battenberg M., Bonci F., Pistello M., Löchelt M., Cichutek K. Multiple restrictions of human immunodeficiency virus type 1 in feline cells. J. Virol. 2007, 81(13):7048-7060.
27. Münk C., Beck T., Zielonka J., Hotz-Wagenblatt A., Chareza S., Battenberg M., Thielebein J., Cichutek K., Bravo I.G., O'Brien S.J., Löchelt M., Yuhki N. Functions, structure, and read-through alternative splicing of feline APOBEC3 genes. Genome Biol. 2008, 9(3):R48.
28. Münk C., Hechler T., Chareza S., Löchelt M. Restriction of feline retroviruses: lessons from cat APOBEC3 cytidine deaminases and TRIM5alpha proteins. Vet. Immunol. Immunopathol. 2010, 134(1-2):14-24.
29. Okeoma C.M., Lovsin N., Peterlin B.M., Ross S.R. APOBEC3 inhibits mouse mammary tumour virus replication in vivo. Nature 2007, 445(7130):927-930.
30. Pecon-Slattery J., Troyer J.L., Johnson W.E., O'Brien S.J. Evolution of felineimmunodeficiency virus in Felidae: implications for human health and wildlife ecology. Vet. Immunol. Immunopathol. 2008, 123(1-2):32-44.
31. Perkovic M., Schmidt S., Marino D., Russell R.A., Stauch B., Hofmann H., Kopietz F., Kloke B.P., Zielonka J., Strover H., Hermle J., Lindemann D., Pathak V.K., Schneider G., Löchelt M., Cichutek K., Münk C. Species-specific inhibition of APOBEC3C by the prototype foamy virus protein bet. J. Biol. Chem. 2009, 284(9):5819-5826.
32. Refsland E.W., Stenglein M.D., Shindo K., Albin J.S., Brown W.L., Harris R.S. Quantitative profiling of the full APOBEC3 mRNA repertoire in lymphocytes and tissues: implications for HIV-1 restriction. Nucleic Acids Res. 2010, 38(13):4274-4284.
33. Rethwilm A. Foamy virus vectors: an awaited alternative to gammaretro- and lentiviral vectors. Curr Gene Ther 2007, 7(4):261-271.
34. Rethwilm A. Molecular biology of foamy viruses. Med. Microbiol. Immunol. 2010, 199(3):197-207.
35. Romen F., Pawlita M., Sehr P., Bachmann S., Schröder J., Lutz H., Löchelt M. Antibodies against Gag are diagnostic markers for feline foamy virus infections while Env and Bet reactivity is undetectable in a substantial fraction of infected cats. Virology 2006, 345(2):502-508.
36. Romen F., Backes P., Materniak M., Sting R., Vahlenkamp T.W., Riebe R., Pawlita M., Kuzmak J., Löchelt M. Serological detection systems for identification of cows shedding bovine foamy virus via milk. Virology 2007, 364(1):123-131.
37. Russell R.A., Wiegand H.L., Moore M.D., Schafer A., McClure M.O., Cullen B.R. Foamy virus Bet proteins function as novel inhibitors of the APOBEC3 family of innate antiretroviral defense factors. J. Virol. 2005, 79(14):8724-8731.
38. Saib A. Non-primate foamy viruses. Curr. Top. Microbiol. Immunol. 2003, 277:197-211.
39. Saib A., Koken M.H., van der Spek P., Peries J., de The H. Involvement of a spliced and defective human foamy virus in the establishment of chronic infection. J. Virol. 1995, 69(9):5261-5268.
40. Santiago M.L., Montano M., Benitez R., Messer R.J., Yonemoto W., Chesebro B., Hasenkrug K.J., Greene W.C. Apobec3 encodes Rfv3, a gene influencing neutralizing antibody control of retrovirus infection. Science 2008, 321(5894):1343-1346.
41. Schwantes A., Ortlepp I., Löchelt M. Construction and functional characterization of feline foamy virus-based retroviral vectors. Virology 2002, 301(1):53-63.
42. Schwantes A., Truyen U., Weikel J., Weiss C., Löchelt M. Application of chimeric feline foamy virus-based retroviral vectors for the induction of antiviral immunity in cats. J. Virol. 2003, 77(14):7830-7842.
43. Sharp P.M., Hahn B.H. AIDS: prehistory of HIV-1. Nature 2008, 455(7213):605-606.
44. Shindo K., Takaori-Kondo A., Kobayashi M., Abudu A., Fukunaga K., Uchiyama T. The enzymatic activity of CEM15/Apobec-3G is essential for the regulation of the infectivity of HIV-1 virion but not a sole determinant of its antiviral activity. J. Biol. Chem. 2003, 278(45):44412-44416.
45. Shlyakhtenko L.S., Lushnikov A.Y., Li M., Lackey L., Harris R.S., Lyubchenko Y.L. Atomic force microscopy studies provide direct evidence for dimerization of the HIV restriction factor APOBEC3G. J. Biol. Chem. 2011, 286(5):3387-3395.
46. Stauch B., Hofmann H., Perkovic M., Weisel M., Kopietz F., Cichutek K., Münk C., Schneider G. Model structure of APOBEC3C reveals a binding pocket modulating ribonucleic acid interaction required for encapsidation. Proc. Natl. Acad. Sci. U. S. A. 2009, 106(29):12079-12084.
47. Stern M.A., Hu C., Saenz D.T., Fadel H.J., Sims O., Peretz M., Poeschla E.M. Productive replication of Vif-chimeric HIV-1 in feline cells. J. Virol. 2010, 84(14):7378-7395.
48. Switzer W.M., Bhullar V., Shanmugam V., Cong M.E., Parekh B., Lerche N.W., Yee J.L., Ely J.J., Boneva R., Chapman L.E., Folks T.M., Heneine W. Frequent simian foamy virus infection in persons occupationally exposed to nonhuman primates. J. Virol. 2004, 78(6):2780-2789.
49. Switzer W.M., Salemi M., Shanmugam V., Gao F., Cong M.E., Kuiken C., Bhullar V., Beer B.E., Vallet D., Gautier-Hion A., Tooze Z., Villinger F., Holmes E.C., Heneine W. Ancient co-speciation of simian foamy viruses and primates. Nature 2005, 434(7031):376-380.
50. Trobridge G.D. Foamy virus vectors for gene transfer. Expert. Opin. Biol. Ther. 2009, 9(11):1427-1436.
51. Wang J., Zhang W., Lv M., Zuo T., Kong W., Yu X. Identification of a cullin5-elonginB-elonginC E3 complex in the degradation of FIV Vif-mediated feline APOBEC3 proteins. J. Virol. 2011, 10.1128/JVI-05218-11.
52. Wongsrikeao P., Saenz D., Rinkoski T., Otoi T., Poeschla E. Antiviral restriction factor transgenesis in the domestic cat. Nat. Methods 2011, 8(10):853-859.
53. Zemba M., Alke A., Bodem J., Winkler I.G., Flower R.L., Pfrepper K., Delius H., Flügel R.M., Löchelt M. Construction of infectious feline foamy virus genomes: cat antisera do not cross-neutralize feline foamy virus chimera with serotype-specific Env sequences. Virology 2000, 266(1):150-156.
54. Zielonka J., Marino D., Hofmann H., Yuhki N., Löchelt M., Münk C. Vif of feline immunodeficiency virus from domestic cats protects against APOBEC3 restriction factors from many felids. J. Virol. 2010, 84(14):7312-7324.